Stifel Nicolaus Reaffirms Buy Rating for Stericycle (SRCL)
Stifel Nicolaus reissued their buy rating on shares of Stericycle (NASDAQ:SRCL) in a research report sent to investors on Thursday morning, Marketbeat.com reports. They currently have a $85.00 price target on the business services provider’s stock.
SRCL has been the subject of a number of other reports. Zacks Investment Research cut shares of Stericycle from a hold rating to a sell rating in a research report on Wednesday, October 4th. Barrington Research lowered their price objective on shares of Stericycle from $87.00 to $75.00 and set an outperform rating for the company in a research report on Friday, November 10th. Jefferies Group set a $83.00 price objective on shares of Stericycle and gave the stock a buy rating in a research report on Wednesday, December 13th. BidaskClub upgraded shares of Stericycle from a strong sell rating to a sell rating in a research report on Saturday, December 2nd. Finally, Oppenheimer reiterated a hold rating on shares of Stericycle in a research report on Wednesday, December 13th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. Stericycle presently has a consensus rating of Hold and a consensus target price of $74.45.
Stericycle (NASDAQ SRCL) opened at $67.99 on Thursday. The company has a market cap of $5,794.26, a P/E ratio of -119.28, a PEG ratio of 1.65 and a beta of 0.16. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.93. Stericycle has a 12-month low of $61.25 and a 12-month high of $88.00.
Stericycle (NASDAQ:SRCL) last issued its earnings results on Wednesday, November 8th. The business services provider reported $1.10 EPS for the quarter, missing the consensus estimate of $1.14 by ($0.04). The firm had revenue of $883.00 million during the quarter, compared to analyst estimates of $896.81 million. Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. Stericycle’s quarterly revenue was down .8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.24 earnings per share. sell-side analysts predict that Stericycle will post 4.5 earnings per share for the current fiscal year.
In other Stericycle news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction that occurred on Monday, October 30th. The shares were sold at an average price of $70.52, for a total value of $1,392,981.56. Following the completion of the transaction, the director now directly owns 205,576 shares in the company, valued at approximately $14,497,219.52. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Over the last 90 days, insiders sold 79,012 shares of company stock valued at $5,240,668. Corporate insiders own 3.50% of the company’s stock.
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Atlantic Trust Group LLC acquired a new position in Stericycle in the 3rd quarter valued at approximately $2,304,000. AXA increased its position in Stericycle by 1,090.5% in the 3rd quarter. AXA now owns 124,875 shares of the business services provider’s stock valued at $8,943,000 after acquiring an additional 114,386 shares during the period. GSA Capital Partners LLP acquired a new position in Stericycle in the 3rd quarter valued at approximately $532,000. Gofen & Glossberg LLC IL increased its position in Stericycle by 2.7% in the 3rd quarter. Gofen & Glossberg LLC IL now owns 65,415 shares of the business services provider’s stock valued at $4,685,000 after acquiring an additional 1,724 shares during the period. Finally, IFM Investors Pty Ltd acquired a new position in Stericycle in the 3rd quarter valued at approximately $265,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.